Retrospective analysis of glioblastoma multiforme (GBM) patients treated initially with BCNU compared to temozolomide (TMZ) with concomitant radiation therapy

被引:0
|
作者
Vinjamuri, M. [1 ]
Adumala, R. [1 ]
Altaha, R. [1 ]
Hobbs, J. [1 ]
Crowell, E. [1 ]
机构
[1] West Virginia Univ, Morgantown, WV USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2071
引用
收藏
页数:2
相关论文
共 50 条
  • [1] RETROSPECTIVE ANALYSIS OF GLIOBLASTOMA (GBM) PATIENTS TREATED WITH TEMOZOLOMIDE (TMZ)-RADIOTHERAPY FOLLOWED BY TMZ FOR 2 YEARS OR UNTIL PROGRESSION: SURVIVAL ANALYSIS
    Muggeri, Alejandro D.
    Alderuccio, Juan Pablo
    Martinetto, Horacio
    Diez, Blanca D.
    NEURO-ONCOLOGY, 2009, 11 (06) : 948 - 948
  • [2] Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM)
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Peters, K.
    Kirkpatrick, J.
    Herndon, J. E.
    Marcello, J.
    Bailey, L.
    Threatt, S.
    Friedman, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Outcome of grade 3 and 4 cytopenia in newly diagnosed glioblastoma multiforme (GBM) patients treated with temozolomide (TMZ).
    Sanchez, B. E.
    Munoz, J.
    Ali, H. Y.
    Anderson, J. M.
    Kuriakose, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] RADIATION THERAPY (RT) AND TEMOZOLAMIDE (TMZ) AS ADJUVANT THERAPY IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM). PRELIMINARY DATA
    Iodice, G.
    Fusco, V.
    Tartarone, A.
    Bochicchio, A. M.
    Capobianco, A.
    Coccaro, M. R.
    Di Leo, P.
    Romano, G. P.
    Castaldo, G.
    Montagna, A.
    Lapadula, L.
    ANNALS OF ONCOLOGY, 2004, 15 : 87 - 87
  • [5] Intra-carotid chemo (ICC) followed by radiation (RT) with concomitant temozolamide (TMZ) and subsequent maintenance TMZ therapy in patients (pts) with glioblastoma multiforme (GBM).
    Mohin, G.
    Davis, R.
    Meek, A.
    Rosiello, A.
    Roque, C.
    Hentschel, P.
    Roche, P.
    Manzione, J.
    Vacirca, J.
    Madajewicz, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 71S - 71S
  • [6] Randomized phase II trial of erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): EORTC 26034
    Van den Bent, Martin
    Brandes, Alba
    Rampling, Roy
    Kouwenhoven, Mathilde
    Kros, Johan M.
    Carpentier, Antoine
    Clement, Paul
    Klughammer, Barbara
    Bakker, Brenda
    Lacombe, Denis
    Gorlia, Thierry
    NEURO-ONCOLOGY, 2007, 9 (04) : 522 - 522
  • [7] Randomized phase II trial of erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): EORTC 26034
    Van Den Bent, M. J.
    Brandes, A.
    Rampling, R.
    Kouwenhoven, M.
    Kros, J. M.
    Carpentier, A. F.
    Clement, P.
    Klughammer, B.
    Gorlia, T.
    Lacombe, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Phase I/II study of enzastaurin (ENZ) plus temozolomide (TMZ) and radiation therapy (XRT) in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS)
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Page, M.
    Rabbitt, J.
    Fedoroff, A.
    Parvataneni, R.
    Nicol, S. J.
    Thornton, D.
    Prados, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] A phase II trial (N0177) of erlotinib and temozolomide (TMZ) combined with radiation therapy (RT) in glioblastoma multiforme (GBM)
    Brown, P. D.
    Krishnan, S.
    Sarkaria, J.
    Wu, W.
    Mischel, P.
    Yong, W. H.
    Arusell, R.
    Jenkins, R. B.
    Buckner, J. C.
    Giannini, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] RADIOTHERAPY AND ADJUVANT TEMOZOLOMIDE COMPARED WITH RADIOTHERAPY AND CONCOMITANT PLUS ADJUVANT TEMOZOLOMIDE IN SURGICALLY TREATED PATIENTS WITH GLIOBLASTOMA MULTIFORME: A RETROSPECTIVE SINGLE INSTITUTION STUDY
    Goeppert, M.
    Felsberg, J.
    Stummer, W.
    Reifenberger, G.
    Steiger, H.
    Sabel, M.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1124 - 1124